Health Analysis: Beyond Data: Empowering Patients and Providers to Manage Risk and Improve HealthcareReport as inadecuate



 Health Analysis: Beyond Data: Empowering Patients and Providers to Manage Risk and Improve Healthcare


Health Analysis: Beyond Data: Empowering Patients and Providers to Manage Risk and Improve Healthcare - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Health Analysis: Beyond Data: Empowering Patients and Providers to Manage Risk and Improve Healthcare
In February of 2011, the U.S. Food and Drug Administration (FDA) issued a new black box warning label on fluoroquinolone medications regarding a recently identified risk for those with myasthenia gravis. Myasthenia gravis is an autoimmune disorder that causes muscle weakness and fatigue. The warning alerts patients to the potential worsening of symptoms if taking fluoroquinolones, a commonly prescribed antibiotic. An estimated 400 Sailors, Marines or their family members were diagnosed with myasthenia gravis between fiscal years 2006 and 2012. Though myasthenia gravis is rare, no cure exists.



Author: U.S. Navy and Marine Corps Public Health Center

Source: https://archive.org/







Related documents